Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Nir Gal Or, Dr"
4,575
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT02605395
Completed
Phase 4
Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions
GlaxoSmithKline
ClinicalTrials.gov
NCT02605395
Completed
Phase 4
Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under...
GlaxoSmithKline
NCT02446483
Completed
Phase 4
A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults
GlaxoSmithKline
ClinicalTrials.gov
NCT02446483
Completed
Phase 4
A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After...
GlaxoSmithKline
NCT02477306
Completed
Phase 1
A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)
Genuine Research Center, Egypt
ClinicalTrials.gov
NCT02477306
Completed
Phase 1
A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) an...
Genuine Research Center,...
NCT06346327
Completed
Clinical Significance Of Intermittently Absent End-Diastolic Flow Of The Fetal Umbilical Artery On Perinatal And Neonatal Outcomes Dr. Zeynep Kayaoğlu Yıldırım Dr. Alperen İnce Dr Gökhan Bayanmelek Dr Gökhan Bolluk
Başakşehir Çam & Sakura City Hospital
ClinicalTrials.gov
NCT06346327
Completed
-
Clinical Significance Of Intermittently Absent End-Diastolic Flow Of The Fetal U...
Başakşehir Çam & Sakura C...
NCT04360772
Withdrawn
Monitoring of Corticosteroids Induced Immunosuppression Using Monocyte Human Leukocyte Antigen-DR (mHLA-DR).
Hospices Civils de Lyon
ClinicalTrials.gov
NCT04360772
Withdrawn
-
Monitoring of Corticosteroids Induced Immunosuppression Using Monocyte Human Leu...
Hospices Civils de Lyon
NCT00196391
Completed
Phase 2
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Duramed Research
ClinicalTrials.gov
NCT00196391
Completed
Phase 2
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Duramed Research
NCT06513520
Completed
Evaluation of Monocyte Expression of HLA-DR (mHLA-DR) in Geriatric Service
Hospices Civils de Lyon
ClinicalTrials.gov
NCT06513520
Completed
-
Evaluation of Monocyte Expression of HLA-DR (mHLA-DR) in Geriatric Service
Hospices Civils de Lyon
NCT03995537
Completed
Monocytic Expression of HLA-DR After Liver Transplantation
Hospices Civils de Lyon
ClinicalTrials.gov
NCT03995537
Completed
-
Monocytic Expression of HLA-DR After Liver Transplantation
Hospices Civils de Lyon
NCT05546632
Completed
Evaluation of Cyto-chex Tubes for the Measurement of Monocyte Expression of Human Leukocyte Antigen - DR Isotype (HLA-DR) Molecules by Flow Cytometry
Hospices Civils de Lyon
ClinicalTrials.gov
NCT05546632
Completed
-
Evaluation of Cyto-chex Tubes for the Measurement of Monocyte Expression of Huma...
Hospices Civils de Lyon
NCT06492707
Suspended
Phase 1
DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial
Fred Hutchinson Cancer Center
ClinicalTrials.gov
NCT06492707
Suspended
Phase 1
DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Rel...
Fred Hutchinson Cancer Ce...
NCT01132196
Completed
Phase 1
Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed Conditions
Dr. Reddy's Laboratories Limited
ClinicalTrials.gov
NCT01132196
Completed
Phase 1
Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under...
Dr. Reddy's Laboratories...
NCT03264976
Unknown
Role of the Serum Exosomal miRNA in Diabetic Retinopathy (DR)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
ClinicalTrials.gov
NCT03264976
Unknown
-
Role of the Serum Exosomal miRNA in Diabetic Retinopathy (DR)
Shanghai General Hospital...
NCT05552222
Recruiting
Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Janssen Research & Development, LLC
ClinicalTrials.gov
NCT05552222
Recruiting
Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR)...
Janssen Research & Develo...
NCT01170169
Completed
Phase 1
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions
Dr. Reddy's Laboratories Limited
ClinicalTrials.gov
NCT01170169
Completed
Phase 1
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Unde...
Dr. Reddy's Laboratories...
NCT01170182
Completed
Phase 1
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition
Dr. Reddy's Laboratories Limited
ClinicalTrials.gov
NCT01170182
Completed
Phase 1
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Unde...
Dr. Reddy's Laboratories...
NCT02659683
Completed
Phase 1
Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions
Torrent Pharmaceuticals Limited
ClinicalTrials.gov
NCT02659683
Completed
Phase 1
Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR...
Torrent Pharmaceuticals L...
NCT04935749
Unknown
Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs
Alexandria University
ClinicalTrials.gov
NCT04935749
Unknown
-
Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field...
Alexandria University
NCT01283919
Completed
Phase 1
Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
Dr. Reddy's Laboratories Limited
ClinicalTrials.gov
NCT01283919
Completed
Phase 1
Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Labo...
Dr. Reddy's Laboratories...
NCT01283932
Completed
Phase 1
Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition
Dr. Reddy's Laboratories Limited
ClinicalTrials.gov
NCT01283932
Completed
Phase 1
Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Labo...
Dr. Reddy's Laboratories...
NCT06198543
Unknown
Study on Exosome Changes in Patients With Proliferative Diabetic Retinopathy
Xuanwu Hospital, Beijing
ClinicalTrials.gov
NCT06198543
Unknown
-
Study on Exosome Changes in Patients With Proliferative Diabetic Retinopathy
Xuanwu Hospital, Beijing
Result Breakdown
Status
Completed
14 (70%)
Unknown
3 (15%)
Withdrawn
1 (5%)
Suspended
1 (5%)
Recruiting
1 (5%)
Phase
Phase 1
8 (40%)
Not Specified
8 (40%)
Phase 4
2 (10%)
Phase 2
1 (5%)
Phase 3
1 (5%)
Top Conditions
Healthy
4 (20%)
Diabetic Retinopathy
3 (15%)
Gastrointestinal Diseases
2 (10%)
Show 7 more
Top Sponsors
Dr. Reddy's Laboratories Limited
5 (25%)
Hospices Civils de Lyon
4 (20%)
GlaxoSmithKline
3 (15%)
Show 7 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease